NYSE:HR - Healthcare Realty Trust Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $31.80
  • Forecasted Upside: 20.05 %
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$26.49
▼ -1.37 (-4.92%)

This chart shows the closing price for HR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Healthcare Realty Trust Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HR

Analyst Price Target is $31.80
▲ +20.05% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Healthcare Realty Trust in the last 3 months. The average price target is $31.80, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 20.05% upside from the last price of $26.49.

This chart shows the closing price for HR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 7 polled investment analysts is to hold stock in Healthcare Realty Trust. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 0 sell ratings
1/11/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/11/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/10/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/8/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/6/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/6/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/5/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/5/2022

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/22/2022BMO Capital MarketsInitiated CoverageHold$28.00Low
6/3/2022Capital One FinancialInitiated CoverageOverweight ➝ Overweight$33.00Low
5/10/2022Berenberg BankDowngradeBuy ➝ Hold$35.00 ➝ $32.00Low
4/26/2022BarclaysInitiated CoverageOverweight$33.00Low
2/1/2022Credit Suisse GroupInitiated CoverageOutperformMedium
1/7/2022BMO Capital MarketsDowngradeOutperform ➝ Market Perform$34.00High
8/20/2021Raymond JamesDowngradeStrong-Buy ➝ Market PerformLow
7/29/2021Morgan StanleyBoost Price TargetEqual Weight$31.00 ➝ $33.00Low
3/31/2021Wells Fargo & CompanyBoost Price TargetEqual Weight$29.00 ➝ $31.00High
3/15/2021Morgan StanleyBoost Price TargetEqual Weight$30.00 ➝ $31.00High
1/28/2021ScotiabankInitiated CoverageSector Perform$32.00Medium
1/13/2021Jefferies Financial GroupUpgradeHold ➝ Buy$30.00 ➝ $33.00High
9/18/2020Capital One FinancialUpgradeEqual Weight ➝ Overweight$33.00High
9/1/2020Stifel NicolausReiterated RatingBuy$32.00Medium
8/31/2020Raymond JamesUpgradeOutperform ➝ Strong-Buy$34.00 ➝ $35.00Low
8/5/2020Capital One FinancialReiterated RatingEqual WeightLow
7/2/2020CitigroupBoost Price TargetNeutral$29.00 ➝ $30.00Low
4/29/2020Raymond JamesLower Price TargetOutperform$38.00 ➝ $34.00High
4/28/2020Wells Fargo & CompanyReiterated RatingHoldHigh
4/7/2020CitigroupDowngradeBuy ➝ Neutral$38.00 ➝ $29.00High
4/3/2020Wells Fargo & CompanyLower Price TargetEqual Weight$33.00 ➝ $26.00Low
4/3/2020JPMorgan Chase & Co.Lower Price TargetNeutral$35.00 ➝ $30.00Low
3/26/2020Morgan StanleyLower Price TargetEqual Weight$33.00 ➝ $25.00High
3/12/2020Raymond JamesBoost Price TargetOutperform$36.00 ➝ $38.00High
3/9/2020BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$35.00 ➝ $43.00High
2/13/2020BMO Capital MarketsReiterated RatingHold$35.00Low
12/20/2019MizuhoReiterated RatingNeutral$34.00Medium
12/12/2019CitigroupUpgradeNeutral ➝ Buy$34.00 ➝ $38.00Medium
11/26/2019Stifel NicolausUpgradeHold ➝ Buy$33.00 ➝ $35.00High
11/6/2019BMO Capital MarketsReiterated RatingHold$31.00Low
9/17/2019Morgan StanleyBoost Price TargetEqual Weight$31.00 ➝ $33.00Low
9/12/2019Berenberg BankInitiated CoverageBuyLow
8/1/2019Capital One FinancialReiterated RatingEqual WeightLow
6/20/2019CitigroupInitiated CoverageNeutral ➝ Neutral$34.00Low
5/13/2019Raymond JamesUpgradeMkt Perform ➝ Outperform$34.00Medium
3/28/2019Morgan StanleySet Price TargetHold$31.00Medium
1/8/2019Raymond JamesUpgradeUnderperform ➝ Market PerformHigh
12/11/2018Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformMedium
11/13/2018MizuhoUpgradeNeutral ➝ Buy$32.00Low
10/18/2018Raymond JamesInitiated CoverageUnderperform ➝ UnderperformLow
8/16/2018Morgan StanleyDowngradeOverweight ➝ Equal Weight$29.00 ➝ $28.00High
8/13/2018MizuhoReiterated RatingHold$28.00Low
6/28/2018Capital One FinancialInitiated CoverageEqual Weight$30.00Low
6/14/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$32.00 ➝ $29.00Low
4/24/2018Stifel NicolausDowngradeBuy ➝ Hold$30.00 ➝ $28.00High
4/2/2018MizuhoReiterated RatingHold$27.00Medium
3/27/2018BMO Capital MarketsReiterated RatingHold$31.00Low
3/20/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$35.00 ➝ $32.00High
3/16/2018Cantor FitzgeraldLower Price TargetOverweight$34.00Low
2/23/2018MizuhoReiterated RatingHold$29.00Low
2/16/2018BMO Capital MarketsReiterated RatingHold$32.00Medium
2/15/2018SunTrust BanksSet Price TargetHold$30.00Low
2/15/2018Stifel NicolausLower Price TargetBuy ➝ Buy$34.00 ➝ $30.00Low
2/14/2018Cantor FitzgeraldReiterated RatingBuy$38.00Low
1/22/2018SunTrust BanksSet Price TargetHold$32.00Low
1/9/2018BMO Capital MarketsDowngradeOutperform ➝ Market Perform$33.00N/A
12/22/2017KeyCorpReiterated RatingEqual WeightLow
12/14/2017Morgan StanleyReiterated RatingOverweight$34.00Low
11/5/2017MizuhoReiterated RatingHold$34.00N/A
11/3/2017Stifel NicolausReiterated RatingBuy$34.00N/A
11/2/2017BMO Capital MarketsReiterated RatingBuy$34.00N/A
10/29/2017KeyCorpSet Price TargetSell$25.00N/A
10/27/2017MizuhoReiterated RatingHold$35.00N/A
10/2/2017BMO Capital MarketsReiterated RatingBuy$34.00Low
9/26/2017KeyCorpReiterated RatingSell$25.00Low
9/25/2017Morgan StanleyBoost Price TargetOverweight$32.50 ➝ $34.00Low
8/24/2017KeyCorpReiterated RatingSell$25.00Low
8/23/2017Cantor FitzgeraldReiterated RatingBuyLow
8/15/2017Cantor FitzgeraldReiterated RatingBuy$38.00Low
8/10/2017Jefferies Financial GroupReiterated RatingHold$36.00 ➝ $34.00Low
8/4/2017Stifel NicolausReiterated RatingBuyLow
7/17/2017Jefferies Financial GroupReiterated RatingHold$36.00Low
(Data available from 7/5/2017 forward)

News Sentiment Rating

1.18 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/7/2021
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/6/2022
  • 3 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/5/2022
  • 19 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/7/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/6/2022
  • 6 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/6/2022
  • 9 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/5/2022
  • 13 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/5/2022

Current Sentiment

  • 13 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Healthcare Realty Trust logo
Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September 30, 2020, the Company owned 211 real estate properties in 24 states totaling 15.5 million square feet and was valued at approximately $5.5 billion. The Company provided leasing and property management services to 11.9 million square feet nationwide.
Read More

Today's Range

Now: $26.49
Low: $25.49
High: $27.83

50 Day Range

MA: $27.95
Low: $24.90
High: $30.88

52 Week Range

Now: $26.49
Low: $24.36
High: $33.77

Volume

8,088,398 shs

Average Volume

3,360,506 shs

Market Capitalization

$4.02 billion

P/E Ratio

47.30

Dividend Yield

4.45%

Beta

0.61

Frequently Asked Questions

What sell-side analysts currently cover shares of Healthcare Realty Trust?

The following Wall Street analysts have issued research reports on Healthcare Realty Trust in the last twelve months: Barclays PLC, Berenberg Bank, BMO Capital Markets, Capital One Financial Co., Credit Suisse Group AG, Morgan Stanley, Raymond James, StockNews.com, and TheStreet.
View the latest analyst ratings for HR.

What is the current price target for Healthcare Realty Trust?

0 Wall Street analysts have set twelve-month price targets for Healthcare Realty Trust in the last year. Their average twelve-month price target is $31.80, suggesting a possible upside of 20.0%.
View the latest price targets for HR.

What is the current consensus analyst rating for Healthcare Realty Trust?

Healthcare Realty Trust currently has 4 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in HR, but not buy more shares or sell existing shares.
View the latest ratings for HR.

How do I contact Healthcare Realty Trust's investor relations team?

Healthcare Realty Trust's physical mailing address is 3310 WEST END AVE SUITE 700, NASHVILLE TN, 37203. The real estate investment trust's listed phone number is (615) 269-8175 and its investor relations email address is [email protected] The official website for Healthcare Realty Trust is www.healthcarerealty.com. Learn More about contacing Healthcare Realty Trust investor relations.